Michael Koblish

Michael Koblish

UNVERIFIED PROFILE

Are you Michael Koblish?   Register this Author

Register author
Michael Koblish

Michael Koblish

Publications by authors named "Michael Koblish"

Are you Michael Koblish?   Register this Author

15Publications

374Reads

35Profile Views

Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.

Bioorg Med Chem Lett 2009 Oct 21;19(20):5931-5. Epub 2009 Aug 21.

Department of Chemistry, Adolor Corporation, 700 Pennsylvania Drive, Exton, PA 19341, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.08.063DOI Listing
October 2009

Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.

Bioorg Med Chem Lett 2008 May 7;18(9):2830-5. Epub 2008 Apr 7.

Department of Chemistry, Adolor Corporation, 700 Pennsylvania Drive, Exton, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.04.006DOI Listing
May 2008

Novel malonamide derivatives as potent kappa opioid receptor agonists.

Bioorg Med Chem Lett 2007 Apr 25;17(7):1951-5. Epub 2007 Jan 25.

Department of Chemistry, Adolor Corporation, 700 Pennsylvania Drive, Exton, PA 19341, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.01.053DOI Listing
April 2007

Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain.

Eur J Pain 2006 Aug 24;10(6):505-12. Epub 2005 Aug 24.

Department of Pharmacology, Adolor Corporation, Exton, PA 19341, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpain.2005.07.004DOI Listing
August 2006

Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.

Eur J Pharmacol 2005 Dec 28;527(1-3):172-4. Epub 2005 Nov 28.

Adolor Corporation, Department of Pharmacology, 700 Pennsylvania Drive, Exton, PA 19341, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2005.10.020DOI Listing
December 2005

Azepinone as a conformational constraint in the design of kappa-opioid receptor agonists.

Bioorg Med Chem Lett 2004 Nov;14(22):5693-7

Department of Chemistry, Adolor Corporation, 700 Pennsylvania Drive, Exton, PA 19341, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.08.041DOI Listing
November 2004